VEENA ABRAHAM: Open Payments
NPI 1770651572 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 12 payments from 5 companies in 2025. Trend: 2023 $125 · 2024 $379 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $591 |
| Neurocrine BioSciences, Inc. | 3 | $388 |
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Alkermes, Inc. | 1 | $127 |
| Luye Pharma (USA) Ltd. | 1 | $126 |
Products named: COBENFY, INGREZZA, ARISTADA, ERZOFRI EXTENDED-RELEASE, REXULTI, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
